Transcription factor 7-like 2 (TCF7L2) gene polymorphism rs7903146 is associated with stroke in type 2 diabetes patients with long disease duration

Diabetes Research and Clinical Practice

Volumn 103, Issue 3, 2014, Pages

  Choi, Hyung Jin ^a   Lee, Dong Hwa ^a   Jeon, Hyun Jeong ^a   Kim, Dae Soon ^a   Lee, Yong Hee ^a   Oh, Taekeun ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Complication; SNP; TCF7L2

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE;

COMPLICATION; SNP; TCF7L2;

ADULT; ALLELES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROGNOSIS; RISK FACTORS; STROKE; TIME FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84898902964     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.051     Document Type: Article

References (10)

1. Grant S.F. Understanding the elusive mechanism of action of TCF7L2 in metabolism. Diabetes 2012, 61:2657-2658.
2. Mondal A.K., Das S.K., Baldini G., Chu W.S., Sharma N.K., Hackney O.G., et al. Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans. J Clin Endocrinol Metab 2010, 95:1450-1457.
3. Sousa A.G., Marquezine G.F., Lemos P.A., Martinez E., Lopes N., Hueb W.A., et al. TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS ONE 2009, 4:e7697.
4. Muendlein A., Saely C.H., Geller-Rhomberg S., Sonderegger G., Rein P., Winder T., et al. Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. PLoS ONE 2011, 6:e17978.
5. Buraczynska M., Swatowski A., Markowska-Gosik D., Kuczmaszewska A., Ksiazek A. Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract 2011, 93:390-395.
6. Luo J., Zhao L., Chen A.Y., Zhang X., Zhu J., Zhao J., et al. TCF7L2 variation and proliferative diabetic retinopathy. Diabetes 2013.
7. Ciccacci C., Di Fusco D., Cacciotti L., Morganti R., D'Amato C., Novelli G., et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol 2012.
8. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
9. Lyssenko V., Lupi R., Marchetti P., Del Guerra S., Orho-Melander M., Almgren P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117:2155-2163.
10. Kaminska D., Kuulasmaa T., Venesmaa S., Kakela P., Vaittinen M., Pulkkinen L., et al. Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism. Diabetes 2012, 61:2807-2813.